Skip to main content

[]

Intended for healthcare professionals
Skip to main content

Abstract

Skin cancer is the most common cancer within the United States. Reports estimate that 1 in 5 Americans will develop some form of skin cancer. Eccrine porocarcinoma is a rare type of skin cancer of sweat gland origin. Eccrine porocarcinoma is most commonly found on the lower extremities. Clinically it may appear similar to benign skin lesions and it has significant metastatic potential. The authors present a case report with 22 months’ follow-up. It describes a multiyear delay in diagnosis involving 3 specialties, including primary care, dermatology, and wound physical therapy. Information is given on techniques when high-risk cutaneous cancers are suspected or encountered. A multispecialty treatment plan is discussed.
Levels of Evidence: Level V

Get full access to this article

View all access and purchase options for this article.

References

2. Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol. 2010;146:279-282.
4. Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. Eccrine porocarcinoma: new insights and a systematic review of the literature. Dermatol Surg. 2018;44:1247-1261.
5. Bonadio J, Armstrong W, Gu M. Eccrine porocarcinoma: report of a case with fine needle aspiration cytology, histopathology and immunohistochemistry. Acta Cytol. 2006;50:476-480.
6. Wick MR, Goellner JR, Wolfe JT 3rd, Su WP. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer. 1985;56:1147-1162.
7. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma. A clinicopathologic study of 35 cases. Arch Dermatol. 1983;119:104-114.
8. Song SS, Wu Lee W, Hamman MS, Jiang SI. Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature. Dermatol Surg. 2015;41:301-306.
9. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151:1081-1086.
10. American Cancer Society. Cancer Facts & Figures 2019. American Cancer Society; 2019.
11. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
12. Valdez R, Ouyang L, Bolen J. Public health and rare diseases: oxymoron no more. Prev Chronic Dis. 2016;13:E05.
13. Le NS, Janik S, Liu DT, et al. Eccrine porocarcinoma of the head and neck: meta-analysis of 120 cases. Head Neck. Published online April 21, 2020.
14. Bleier BS, Newman JG, Quon H, Feldman MD, Kent KK, Weinstein GS. Eccrine porocarcinoma of the nose: case report and review of world literature. Arch Otolaryngol Head Neck Surg. 2006;132:215-218.
15. Huet P, Dandurand M, Pignodel C, Guillot B. Metastasizing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol. 1996;35(5 pt 2):860-864.
16. Kolde G, Macher E, Grundmann E. Metastasizing eccrine porocarcinoma. Report of two cases with fatal outcome. Pathol Res Pract. 1991;187:477-481.
17. Grimme H, Petres A, Bergen E, Wiemers S, Schöpf E, Vanscheidt W. Metastasizing porocarcinoma of the head with lethal outcome. Dermatology. 1999;198:298-300.
18. Lehmann C, Rodriguez Ossa P, Vargas Manrique M, Acosta AE, Quintero Pérez Y. Eccrine porocarcinoma with zosteriform metastasis. Cureus. 2020;12:e6873.
19. Khaja M, Ashraf U, Mehershahi S, Ayyadurai P, Malik S. Recurrent metastatic eccrine porocarcinoma: a case report and review of the literature. Am J Case Rep. 2019;20:179-183.
20. Seo BF, Choi HJ, Jung SN. Eccrine porocarcinoma on the cheek. Arch Craniofac Surg. 2019;20:48-50.
21. James W, Berger T, Elston D, Neuhaus I. Andrews’ Diseases of the Skin. 12th ed. Elsevier; 2016:16,881,896,897.
22. Tidwell WJ, Mayer JE, Malone J, Schadt C, Brown T. Treatment of eccrine porocarcinoma with Mohs micrographic surgery: a cases series and literature review. Int J Dermatol. 2015;54:1078-1083.
23. Brown CW Jr, Dy LC. Eccrine porocarcinoma. Dermatol Ther. 2008;21:433-438.
24. Salguero-Fernández I, Rios-Buceta L, Jaén-Olasolo P. Sentinel lymph node in nonmelanoma skin cancer [in Spanish]. Actas Dermosifiliogr. 2011;102:589-598.
25. Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56:292-309.
26. Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-79.
27. Duncan JR, Carr D, Kaffenberger BH. The utility of positron emission tomography with and without computed tomography in patients with nonmelanoma skin cancer. J Am Acad Dermatol. 2016;75:186-196.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
Email Article Link
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: August 17, 2020
Issue published: October 2020

Keywords

  1. lymphoscintigraphy
  2. metastasis
  3. multispecialty
  4. skin cancer

Rights and permissions

© 2020 The Author(s).
Request permissions for this article.
PubMed: 32924585

Authors

Affiliations

Christine Jarocki, DPM
Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Health System, Ann Arbor, Michigan
Jeffery Kozlow, MD, MS
Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
Paul W. Harms, MD, PhD
Department of Pathology, Division of Anatomical Pathology, Dermatopathology, University of Michigan Health System, Ann Arbor, Michigan
Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan (PWH)
Brian M. Schmidt, DPM
Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Health System, Ann Arbor, Michigan

Notes

Christine Jarocki, DPM, Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Health System, 24 Frank Lloyd Wright Drive, Lobby C, Ann Arbor, MI 48106; e-mail: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Foot & Ankle Specialist.

View All Journal Metrics

Article usage*

Total views and downloads: 297

*Article usage tracking started in December 2016


Articles citing this one

Receive email alerts when this article is cited

Web of Science: 2 view articles Opens in new tab

Crossref: 3

  1. Diagnosis and Management of Malignant Epithelial Nail Unit Tumors
    Go to citationCrossrefGoogle Scholar
  2. Porocarcinoma: an epidemiological, clinical, and dermoscopic 20‐year study
    Go to citationCrossrefGoogle Scholar
  3. A systematic review of periungual eccrine neoplasms
    Go to citationCrossrefGoogle Scholar

Figures and tables

Figures & Media

Tables

View Options

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text